Global Automated Cell Processing Systems for Cell Therapy Market Growth 2024-2030

Publication ID:

LPI11244719

Publication Date:

November 11, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Cell processing systems for cell therapy are specialized technologies and equipment used to prepare, manipulate, and manage cells for therapeutic applications. These systems play a crucial role in the development and administration of cell-based treatments, which involve the use of living cells to treat or cure diseases.
The global Automated Cell Processing Systems for Cell Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淎utomated Cell Processing Systems for Cell Therapy Industry Forecast鈥� looks at past sales and reviews total world Automated Cell Processing Systems for Cell Therapy sales in 2023, providing a comprehensive analysis by region and market sector of projected Automated Cell Processing Systems for Cell Therapy sales for 2024 through 2030. With Automated Cell Processing Systems for Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated Cell Processing Systems for Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Automated Cell Processing Systems for Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automated Cell Processing Systems for Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Automated Cell Processing Systems for Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated Cell Processing Systems for Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated Cell Processing Systems for Cell Therapy.
Global key players of Automated And Closed Cell Therapy Processing Systems include Cytiva, Miltenyi Biotec, Thermo Fisher Scientific, Terumo, Merck, etc. The top five players hold a share about 79%. In terms of product type, Non-Stem Cell Therapy is the largest segment, accounting for a share about 90%. In terms of application, Industry is the largest field with a share about 66 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Automated Cell Processing Systems for Cell Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Stem Cell Therapy
Non-Stem Cell Therapy
Segmentation by Application:
Academia
Industrial
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Automated Cell Processing Systems for Cell Therapy market?
What factors are driving Automated Cell Processing Systems for Cell Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Automated Cell Processing Systems for Cell Therapy market opportunities vary by end market size?
How does Automated Cell Processing Systems for Cell Therapy break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Automated Cell Processing Systems for Cell Therapy Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Automated Cell Processing Systems for Cell Therapy by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Automated Cell Processing Systems for Cell Therapy by Country/Region, 2019, 2023 & 2030
2.2 Automated Cell Processing Systems for Cell Therapy Segment by Type
2.2.1 Stem Cell Therapy
2.2.2 Non-Stem Cell Therapy
2.3 Automated Cell Processing Systems for Cell Therapy Sales by Type
2.3.1 Global Automated Cell Processing Systems for Cell Therapy Sales Market Share by Type (2019-2024)
2.3.2 Global Automated Cell Processing Systems for Cell Therapy Revenue and Market Share by Type (2019-2024)
2.3.3 Global Automated Cell Processing Systems for Cell Therapy Sale Price by Type (2019-2024)
2.4 Automated Cell Processing Systems for Cell Therapy Segment by Application
2.4.1 Academia
2.4.2 Industrial
2.5 Automated Cell Processing Systems for Cell Therapy Sales by Application
2.5.1 Global Automated Cell Processing Systems for Cell Therapy Sale Market Share by Application (2019-2024)
2.5.2 Global Automated Cell Processing Systems for Cell Therapy Revenue and Market Share by Application (2019-2024)
2.5.3 Global Automated Cell Processing Systems for Cell Therapy Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Automated Cell Processing Systems for Cell Therapy Breakdown Data by Company
3.1.1 Global Automated Cell Processing Systems for Cell Therapy Annual Sales by Company (2019-2024)
3.1.2 Global Automated Cell Processing Systems for Cell Therapy Sales Market Share by Company (2019-2024)
3.2 Global Automated Cell Processing Systems for Cell Therapy Annual Revenue by Company (2019-2024)
3.2.1 Global Automated Cell Processing Systems for Cell Therapy Revenue by Company (2019-2024)
3.2.2 Global Automated Cell Processing Systems for Cell Therapy Revenue Market Share by Company (2019-2024)
3.3 Global Automated Cell Processing Systems for Cell Therapy Sale Price by Company
3.4 Key Manufacturers Automated Cell Processing Systems for Cell Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Automated Cell Processing Systems for Cell Therapy Product Location Distribution
3.4.2 Players Automated Cell Processing Systems for Cell Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Automated Cell Processing Systems for Cell Therapy by Geographic Region
4.1 World Historic Automated Cell Processing Systems for Cell Therapy Market Size by Geographic Region (2019-2024)
4.1.1 Global Automated Cell Processing Systems for Cell Therapy Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Automated Cell Processing Systems for Cell Therapy Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Automated Cell Processing Systems for Cell Therapy Market Size by Country/Region (2019-2024)
4.2.1 Global Automated Cell Processing Systems for Cell Therapy Annual Sales by Country/Region (2019-2024)
4.2.2 Global Automated Cell Processing Systems for Cell Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Automated Cell Processing Systems for Cell Therapy Sales Growth
4.4 APAC Automated Cell Processing Systems for Cell Therapy Sales Growth
4.5 Europe Automated Cell Processing Systems for Cell Therapy Sales Growth
4.6 Middle East & Africa Automated Cell Processing Systems for Cell Therapy Sales Growth
5 Americas
5.1 Americas Automated Cell Processing Systems for Cell Therapy Sales by Country
5.1.1 Americas Automated Cell Processing Systems for Cell Therapy Sales by Country (2019-2024)
5.1.2 Americas Automated Cell Processing Systems for Cell Therapy Revenue by Country (2019-2024)
5.2 Americas Automated Cell Processing Systems for Cell Therapy Sales by Type (2019-2024)
5.3 Americas Automated Cell Processing Systems for Cell Therapy Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Automated Cell Processing Systems for Cell Therapy Sales by Region
6.1.1 APAC Automated Cell Processing Systems for Cell Therapy Sales by Region (2019-2024)
6.1.2 APAC Automated Cell Processing Systems for Cell Therapy Revenue by Region (2019-2024)
6.2 APAC Automated Cell Processing Systems for Cell Therapy Sales by Type (2019-2024)
6.3 APAC Automated Cell Processing Systems for Cell Therapy Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Automated Cell Processing Systems for Cell Therapy by Country
7.1.1 Europe Automated Cell Processing Systems for Cell Therapy Sales by Country (2019-2024)
7.1.2 Europe Automated Cell Processing Systems for Cell Therapy Revenue by Country (2019-2024)
7.2 Europe Automated Cell Processing Systems for Cell Therapy Sales by Type (2019-2024)
7.3 Europe Automated Cell Processing Systems for Cell Therapy Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Automated Cell Processing Systems for Cell Therapy by Country
8.1.1 Middle East & Africa Automated Cell Processing Systems for Cell Therapy Sales by Country (2019-2024)
8.1.2 Middle East & Africa Automated Cell Processing Systems for Cell Therapy Revenue by Country (2019-2024)
8.2 Middle East & Africa Automated Cell Processing Systems for Cell Therapy Sales by Type (2019-2024)
8.3 Middle East & Africa Automated Cell Processing Systems for Cell Therapy Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Automated Cell Processing Systems for Cell Therapy
10.3 Manufacturing Process Analysis of Automated Cell Processing Systems for Cell Therapy
10.4 Industry Chain Structure of Automated Cell Processing Systems for Cell Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Automated Cell Processing Systems for Cell Therapy Distributors
11.3 Automated Cell Processing Systems for Cell Therapy Customer
12 World Forecast Review for Automated Cell Processing Systems for Cell Therapy by Geographic Region
12.1 Global Automated Cell Processing Systems for Cell Therapy Market Size Forecast by Region
12.1.1 Global Automated Cell Processing Systems for Cell Therapy Forecast by Region (2025-2030)
12.1.2 Global Automated Cell Processing Systems for Cell Therapy Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Automated Cell Processing Systems for Cell Therapy Forecast by Type (2025-2030)
12.7 Global Automated Cell Processing Systems for Cell Therapy Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Cytiva
13.1.1 Cytiva Company Information
13.1.2 Cytiva Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.1.3 Cytiva Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cytiva Main Business Overview
13.1.5 Cytiva Latest Developments
13.2 Miltenyi Biotec
13.2.1 Miltenyi Biotec Company Information
13.2.2 Miltenyi Biotec Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.2.3 Miltenyi Biotec Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Miltenyi Biotec Main Business Overview
13.2.5 Miltenyi Biotec Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.4.3 Terumo Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.5.3 Merck Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.6.3 Fresenius Kabi Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 Sartorius
13.7.1 Sartorius Company Information
13.7.2 Sartorius Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.7.3 Sartorius Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sartorius Main Business Overview
13.7.5 Sartorius Latest Developments
13.8 Lonza
13.8.1 Lonza Company Information
13.8.2 Lonza Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.8.3 Lonza Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Lonza Main Business Overview
13.8.5 Lonza Latest Developments
13.9 Boyalife (ThermoGenesis)
13.9.1 Boyalife (ThermoGenesis) Company Information
13.9.2 Boyalife (ThermoGenesis) Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.9.3 Boyalife (ThermoGenesis) Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boyalife (ThermoGenesis) Main Business Overview
13.9.5 Boyalife (ThermoGenesis) Latest Developments
13.10 EurekaBio
13.10.1 EurekaBio Company Information
13.10.2 EurekaBio Automated Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.10.3 EurekaBio Automated Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 EurekaBio Main Business Overview
13.10.5 EurekaBio Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂